Want to see RYAN full AI Analyst Report?
Top Page
Ryan Specialty Group
(NYSE:RYAN)
Select Model
Select Model
Rating:58Neutral
Price Target:
$43.00
â–²(2.99% Upside)
Action:Reiterated
Date:08/19/26
RYAN’s score is primarily supported by strong revenue growth and solid operating profitability with generally supportive cash generation. The biggest constraints are elevated leverage and a rich valuation (high P/E), which increase downside sensitivity if margins compress as guided or competitive/property pricing pressures persist. Technical signals are mixed, indicating only modest near-term momentum.
Positive Factors
Sustained Revenue Growth and Profitability
Consistent revenue expansion alongside solid operating margins indicates durable demand for Ryan Specialty’s distribution and underwriting platforms. This combination supports ongoing investment, operating leverage and resilience across specialty P&C market cycles.
Negative Factors
Elevated Financial Leverage
High leverage reduces balance-sheet flexibility and increases sensitivity to earnings volatility, refinancing conditions and interest costs. It could constrain strategic investment or shareholder returns if specialty-market growth and profitability weaken.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth and Profitability
Consistent revenue expansion alongside solid operating margins indicates durable demand for Ryan Specialty’s distribution and underwriting platforms. This combination supports ongoing investment, operating leverage and resilience across specialty P&C market cycles.
Read all positive factors
Ryan Specialty Group Key Performance Indicators (KPIs)
Any
Revenue by Geography
Shows where sales are generated across regions or countries, highlighting market concentration and expansion opportunities. For Ryan, geographic splits signal exposure to local insurance markets, regulatory environments, and currency effects — high concentration raises country-specific risk, while broader geographic mix can indicate more resilient growth prospects.
Shows where sales are generated across regions or countries, highlighting market concentration and expansion opportunities. For Ryan, geographic splits signal exposure to local insurance markets, regulatory environments, and currency effects — high concentration raises country-specific risk, while broader geographic mix can indicate more resilient growth prospects.
Data provided by:
The Fly
The FlyRyan Specialty Group (RYAN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$11.07B
Dividend Yield1.18%
Average Volume (3M)2.17M
Price to Earnings (P/E)45.5
Beta (1Y)0.54
Revenue Growth13.83%
EPS Growth69.95%
CountryUS
Employees6,171
SectorFinancial
Sector Strength70
IndustryInsurance - Specialty
Share Statistics
EPS (TTM)0.95
Shares Outstanding122,077,705
10 Day Avg. Volume1,613,217
30 Day Avg. Volume2,169,746
Financial Highlights & Ratios
PEG Ratio-2.88
Price to Book (P/B)10.14
Price to Sales (P/S)2.15
P/FCF Ratio11.41
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$47.42Price Target Upside13.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)2.16
Revenue Forecast (FY)$3.29B
Ryan Specialty Group Business Overview & Revenue Model
Company Description
Ryan Specialty Holdings, Inc. functions as a provider of specialized insurance products and comprehensive solutions for the benefit of insurance brokers, agents, and carriers. The company delivers a range of services including distribution, underw...
How the Company Makes Money
Ryan Specialty makes money primarily by earning fees and commissions tied to placing and managing specialty P&C insurance business. A major revenue stream comes from its wholesale brokerage activities, where it intermediates between retail insuran...
Ryan Specialty Group Earnings Call Summary
Earnings Call Date:Jul 30, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Neutral
The call presented solid financial results — mid-to-high single-digit organic growth, EPS and adjusted EBITDAC expansion, strong underwriting management performance, meaningful share repurchases and progress on AI and platform initiatives. Offsetting these positives are persistent cyclical pressures in property and builders' risk, heightened competition (especially in small commercial and some casualty pockets), and a downward margin guide of ~50–100 basis points for the year. Management emphasized discipline, a strong balance sheet (3.3x leverage) and strategic optionality (buybacks, targeted M&A when available), but near-term execution risks remain in a challenging pricing environment.Positive Updates
Top-line Growth
Total revenue grew 7.2% year-over-year to $917.0 million in Q2 2026, driven by 6.7% organic revenue growth and modest M&A contribution; organic revenue for the first half increased 8.9%.
Negative Updates
Property Pricing and Market Weakness
Property market remained challenging with material pricing declines in catastrophe-exposed and large accounts (management cited declines in cat-exposed pricing as much as 25%–35%); full-year guidance embeds a moderate decline in the property book.
Read all updates
Q2-2026 Updates
Positive
Negative
Top-line Growth
Total revenue grew 7.2% year-over-year to $917.0 million in Q2 2026, driven by 6.7% organic revenue growth and modest M&A contribution; organic revenue for the first half increased 8.9%.
Read all positive updates
Company Guidance
Management guided 2026 organic revenue growth in the mid-single-digits and said they now expect to be toward the higher end of that range, while embedding continued property pricing declines and a moderate full‑year decline in the property book; they expect full‑year adjusted EBITDAC margin to be down roughly 50–100 basis points year‑over‑year (Q2 adjusted EBITDAC was $327M and margin was 35.7%), an adjusted effective tax rate of ~26% for the remainder of 2026, and GAAP net interest expense of ~ $226M for 2026 (with ~$58M to be expensed in Q3). The company ended the quarter at 3.3x total net leverage (comfort corridor 3.0–4.0x), repurchased ~8.1M shares for $260M in Q2 plus ~$42M of repurchases in July and increased buyback authorization by $300M, said a meaningful acquisition in 2026 is unlikely (looking toward 2027), and noted Q3 is their toughest organic growth comp.Ryan Specialty Group Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
46
Neutral
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.22B | 3.05B | 2.52B | 2.08B | 1.73B | 1.43B |
| Gross Profit | 2.61B | 2.76B | 2.52B | 2.08B | 1.73B | 1.43B |
| EBITDA | 789.74M | 803.08M | 598.63M | 473.27M | 393.31M | 253.60M |
| Net Income | 188.04M | 63.40M | 94.67M | 61.04M | 61.05M | 65.87M |
Balance Sheet | ||||||
| Total Assets | 11.97B | 10.56B | 9.65B | 7.25B | 6.38B | 5.46B |
| Cash, Cash Equivalents and Short-Term Investments | 140.12M | 158.32M | 554.14M | 838.79M | 992.72M | 386.96M |
| Total Debt | 3.81B | 3.53B | 3.46B | 2.16B | 2.16B | 1.68B |
| Total Liabilities | 10.95B | 9.31B | 8.55B | 6.27B | 5.57B | 4.86B |
| Stockholders Equity | 509.41M | 648.07M | 627.66M | 559.75M | 478.40M | 343.77M |
Cash Flow | ||||||
| Free Cash Flow | 496.69M | 575.71M | 467.87M | 447.43M | 320.47M | 263.71M |
| Operating Cash Flow | 558.52M | 643.67M | 514.87M | 477.20M | 335.51M | 273.49M |
| Investing Cash Flow | -247.02M | -834.01M | -1.76B | -476.23M | -22.42M | -457.94M |
| Financing Cash Flow | -66.00M | 78.12M | 1.17B | -12.61M | 314.76M | 429.28M |
Ryan Specialty Group Technical Analysis
Positive
41.75
Price Trends
40.56
Positive
36.91
Positive
42.10
Positive
Market Momentum
0.45
Positive
56.00
Neutral
67.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RYAN, the sentiment is Positive. The current price of 41.75 is below the 20-day moving average (MA) of 43.33, above the 50-day MA of 40.56, and below the 200-day MA of 42.10, indicating a neutral trend. The MACD of 0.45 indicates Positive momentum. The RSI at 56.00 is Neutral, neither overbought nor oversold. The STOCH value of 67.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RYAN.
Ryan Specialty Group Risk Analysis
Ryan Specialty Group disclosed 74 risk factors in its most recent earnings report. Ryan Specialty Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Ryan Specialty Group Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | $6.12B | 9.41 | 11.91% | 2.01% | 4.47% | 4.26% | |
81 Outperform | $6.34B | 9.63 | 13.90% | 2.02% | -1.88% | 4.83% | |
78 Outperform | $14.01B | 13.37 | 18.03% | 1.24% | 9.36% | 52.85% | |
75 Outperform | $12.69B | 16.42 | 10.13% | 3.96% | 12.68% | -27.30% | |
71 Outperform | $7.33B | 9.91 | 13.62% | 2.93% | 22.55% | 298.19% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | $11.07B | 45.48 | 31.03% | 1.20% | 13.83% | 69.95% |
* Financial Sector Average
RYAN
Ryan Specialty Group
44.34
-12.98
-22.65%
AIZ
Assurant
287.81
77.09
36.58%
FNF
Fidelity National Financial
47.43
-8.55
-15.28%
FAF
First American Financial
72.26
8.06
12.56%
MTG
MGIC Investment
31.10
3.80
13.90%
ESNT
Essent Group
68.47
6.80
11.02%
Ryan Specialty Group Corporate Events
Business Operations and StrategyRegulatory Filings and Compliance
Ryan Specialty Announces Neutral-Dilution Executive Option Agreement
Positive
Aug 7, 2026
On August 4, 2026, Ryan Specialty Holdings, Inc. and the Ryan Stock Option Trust, overseen by Executive Chairman Patrick G. Ryan and Shirley W. Ryan, amended an existing Executive Chairman Option Settlement Agreement tied to the company’s 20...
Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Ryan Specialty Delivers Solid Q2 Growth Amid Margin Pressure
Positive
Jul 30, 2026
For the second quarter ended June 30, 2026, Ryan Specialty reported total revenue of $916.6 million, up 7.2% year over year, with organic revenue growth of 6.7% and Adjusted EBITDAC rising 6.0% to $326.9 million, while net income fell 13.1% to $10...
Business Operations and StrategyStock Buyback
Ryan Specialty Expands Share Repurchase Authorization to $600 Million
Positive
May 26, 2026
On May 26, 2026, Chicago-based Ryan Specialty Holdings, Inc. announced that its board had increased the authorization for its Class A common stock repurchase program by $300 million, bringing the total program size to $600 million. As of May 22, 2...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.